APA (7th ed.) Citation

GR, F., JR, M., EA, O., JL, S., JL, D., & LM, F. (2023). Association of a novel BRCA2 mutation with prostate cancer risk further supports germline genetic testing. European journal of cancer (Oxford, England : 1990), 180, 155. https://doi.org/10.1016/j.ejca.2022.11.034

Chicago Style (17th ed.) Citation

GR, Foley, Marthick JR, Ostrander EA, Stanford JL, Dickinson JL, and FitzGerald LM. "Association of a Novel BRCA2 Mutation with Prostate Cancer Risk Further Supports Germline Genetic Testing." European Journal of Cancer (Oxford, England : 1990) 180 (2023): 155. https://doi.org/10.1016/j.ejca.2022.11.034.

MLA (9th ed.) Citation

GR, Foley, et al. "Association of a Novel BRCA2 Mutation with Prostate Cancer Risk Further Supports Germline Genetic Testing." European Journal of Cancer (Oxford, England : 1990), vol. 180, 2023, p. 155, https://doi.org/10.1016/j.ejca.2022.11.034.